NORVARA THERAPEUTICS
London
Computational Virology & Gene Therapy
III. PARTNERSHIPS & CAPITAL ALLOCATION
University Labs: Wet-Lab Validation
We generate the IP; you run the biological assays. As a computational-first startup, we maintain a zero-footprint physical lab. We are actively seeking strategic partnerships with elite academic research groups to conduct in-vitro and in-vivo synthesis and validation of our generated capsids.
Propose academic collaboration →Venture Capital: Seed Funding
Norvara is engaging with early-stage biotech, deep-tech, and AI-focused venture funds. Seed capital will be deployed directly into scaling our ML compute architecture, expanding proprietary datasets, and financing our academic validation pipeline.
Request investor deck →Scientific Inquiries
For general scientific correspondence, data inquiries, or technical discussion regarding our computational methodology, please direct your communication to our research office. You may contact the team by writing to research@norvaratx.com. Please note that due to the volume of research correspondence we receive, responses are prioritized based on structural alignment with our current R&D objectives.